SCHEMBL7418878

SCHEMBL7418878

CCc1c(C=O)c2ccc(C(N)=O)cc2n1Cc1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
ALOX5AP P20292 1/20 0.42
DPP4 P27487 3/20 0.42
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TP53 P04637 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MAP3K14 Q99558 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TNF P01375 1/20 0.39
NOD2 Q9HC29 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7462431 0.92 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7420372 0.91 KMT2A (0.56) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7473116 0.88 MAPT (0.48) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7416231 0.86 ALOX5AP (0.44) ALDH1A1MEN1KMT2ALMNAALOX5AP
SCHEMBL7471798 0.84 L3MBTL1 (0.48) ALDH1A1MEN1KMT2ALMNAALOX5AP
SCHEMBL7420966 0.83 ALOX5AP (0.44) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL7420321 0.82 ALOX5AP (0.48) ALDH1A1MEN1KMT2AALOX5APDPP4
SCHEMBL7421444 0.82 KMT2A (0.54) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7427183 0.81 ALOX5AP (0.44) ALDH1A1MEN1KMT2ALMNAALOX5AP
SCHEMBL7428583 0.81 ALOX5AP (0.45) ALDH1A1MEN1KMT2AALOX5APDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed